Showing results (21-30 of 261) with videos related to
Sort By:
Pageof 27
Nanobiomedicine|July 20, 2018
Engineering Iron Oxide Nanoparticles for Clinical SettingsAitziber L Cortajarena, Daniel Ortega, Sandra M Ocampo, et al.Oncotarget|September 3, 2016
Cancer stem cells from human glioblastoma resemble but do not mimic original tumors after in vitro passaging in serum-free mediaNoemí García-Romero, Carmen González-Tejedo, Josefa Carrión-Navarro, et al.Cells|November 14, 2019
Dyskerin Mutations Present in Dyskeratosis Congenita Patients Increase Oxidative Stress and DNA Damage Signalling in Dictyostelium DiscoideumJavier Rodriguez-Centeno, Rosario Perona, Leandro SastreCritical Reviews in Oncology/Hematology|September 13, 2011
Strategies for maintenance therapy in advanced non-small cell lung cancer: current status, unanswered questions and future directionsAna Custodio, Javier de CastroJournal of Neurological Surgery. Part A, Central European Neurosurgery|December 8, 2020
Brain Arteriovenous Malformations: Impact of Neurologic Status, Bleeding, and Type of Treatment on Final OutcomeSara García-Duque, Roberto García-Leal, Begoña Iza-Vallejo, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2009
Telomerase deficiency and cancer susceptibility syndromesRosario Perona, Rosario Machado-Pinilla, Cristina Manguan, et al.International Journal of Molecular Sciences|April 28, 2019
Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung CancerVerónica Moncho-Amor, Laura Pintado-Berninches, Inmaculada Ibañez de Cáceres, et al.Differentiation; Research in Biological Diversity|February 9, 2011
The dual-specificity protein phosphatase MkpB, homologous to mammalian MKP phosphatases, is required for D. discoideum post-aggregative development and cisplatin responseVerónica Moncho-Amor, María Galardi-Castilla, Rosario Perona, et al.Plos One|September 25, 2019
Structure of Dictyostelium discoideum telomeres. Analysis of possible replication mechanismsJavier Rodriguez-Centeno, Cristina Manguán-García, Rosario Perona, et al.Translational Lung Cancer Research|March 26, 2015
KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approachJavier de Castro Carpeño, Cristóbal Belda-IniestaPageof 27